Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18

This study was designed to evaluate B-type natriuretic peptide (BNP) for risk assessment and clinical decision making over a range of cut points, alone and with cardiac troponin I (cTnI), in patients with non-ST-elevation acute coronary syndromes (ACS). B-type natriuretic peptide holds promise for r...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2003-04, Vol.41 (8), p.1264-1272
Hauptverfasser:	MORROW, David A, DE LEMOS, James A, SABATINE, Marc S, MURPHY, Sabina A, DEMOPOULOS, Laura A, DIBATTISTE, Peter M, MCCABE, Carolyn H, GIBSON, C. Michael, CANNON, Christopher P, BRAUNWALD, Eugene
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute coronary syndromes Adult Age Aged Angina, Unstable - blood Angina, Unstable - physiopathology Angina, Unstable - therapy Atrial Natriuretic Factor - blood Biological and medical sciences Biomarkers - blood Cardiology Cardiology. Vascular system Cardiotonic Agents - blood Clinical outcomes Confidence intervals Coronary heart disease Diabetes Female Heart Heart attacks Heart Conduction System - physiopathology Heart failure Heart rate Humans Male Medical imaging Medical sciences Middle Aged Mortality Myocardial Infarction - blood Myocardial Infarction - physiopathology Myocardial Infarction - therapy Natriuretic Peptide, Brain Peptides Predictive Value of Tests Randomized Controlled Trials as Topic Research Design Risk Assessment Shipments Statistical methods Variables
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!